Royal London Asset Management
GMAB icon

Royal London Asset Management’s Genmab GMAB Stock Holding History

Royal London Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-49,849
Closed -$1.25M – 647
2024
Q2 		$1.25M Sell
49,849
-175,556
-78% -$4.98M ﹤0.01% 626
2024
Q1 		$6.74M Sell
225,405
-1,649
-0.7% -$48.4K 0.02% 487
2023
Q4 		$7.23M Sell
227,054
-26,451
-10% -$830K 0.02% 459
2023
Q3 		$8.94M Buy
+253,505
New +$9.66M 0.03% 391

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal London Asset Management's GMAB Position: Q3 2024 in Review

Royal London Asset Management sold out of Genmab (GMAB) in Q3 2024, closing a stake of 49,849 shares — an estimated $1.25M sold.

Royal London Asset Management first reported a position in GMAB in Q3 2023 and held it in 4 quarters. The position peaked at $8.94M in Q3 2023. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • Royal London Asset Management reported no remaining Genmab position as of Q3 2024 after selling out during the quarter.
  • Royal London Asset Management sold 49,849 Genmab shares in Q3 2024, an estimated $1.25M.
  • Royal London Asset Management first reported a position in Genmab in Q3 2023 and held it in 4 quarters.
  • Royal London Asset Management's Genmab position peaked at $8.94M in Q3 2023.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on Royal London Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.